Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 436.55
+11.90 (2.80%)
Jun 11, 2026, 3:30 PM IST
Bliss GVS Pharma Revenue
Bliss GVS Pharma had revenue of 2.57B INR in the quarter ending March 31, 2026, with 29.80% growth. This brings the company's revenue in the last twelve months to 8.68B, up 7.19% year-over-year. In the fiscal year ending March 31, 2025, Bliss GVS Pharma had annual revenue of 8.10B with 5.13% growth.
Revenue (ttm)
8.68B
Revenue Growth
+7.19%
P/S Ratio
5.31
Revenue / Employee
8.99M
Employees
966
Market Cap
46.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.10B | 394.81M | 5.13% |
| Mar 31, 2024 | 7.70B | 186.57M | 2.48% |
| Mar 31, 2023 | 7.52B | 41.33M | 0.55% |
| Mar 31, 2022 | 7.47B | 1.70B | 29.50% |
| Mar 31, 2021 | 5.77B | -1.12B | -16.26% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 48.59B |
| Akums Drugs and Pharmaceuticals | 43.59B |
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.19B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.75B |
| Windlas Biotech | 9.04B |
| Orchid Pharma | 8.11B |
Bliss GVS Pharma News
- 2 days ago - Anupam Rasayan makes Rs 299 per share open offer for Bliss GVS Pharma - Business Upturn
- 2 days ago - Bliss GVS Pharma faces Rs 299 per share open offer from Anupam Rasayan - Business Upturn
- 9 days ago - Bliss GVS Pharma achieves WHO-GMP compliance for manufacturing facility - Business Upturn
- 16 days ago - Why are Bliss GVS Pharma shares rallying over 15% today? Explained - Business Upturn
- 17 days ago - Bliss GVS Pharma shares jump 7% after Anupam Rasayan announces ₹1,369 crore stake acquisition deal - Business Upturn
- 19 days ago - Anupam Rasayan India acquires up to 48.2% stake in Bliss GVS Pharma - Business Upturn
- 19 days ago - Anupam Rasayan India to acquire up to 48.2% stake in Bliss GVS Pharma - Business Upturn
- 19 days ago - Anupam Rasayan to acquire up to 74.20% stake in Bliss GVS Pharma for Rs 1,369 crore - Business Upturn